glp 1 and 2 drugs Comparing Ozempic, Wegovy Other GLP-1 The GLP-1 Agonists and Obesity:

No Generic Available: Eli Lilly holds patents on tirzepatide until around 2036-2040, meaning no true generic versions will be available for years

mean (SD)

| GoodRx

doi: 10.3390/ijms25021211, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 41

Lower incidence of deep vein thrombosis, pulmonary embolism, and pulmonary hypertension, likely due to effects on endothelial function and clotting

The development of these agents underscores the continuous improvement of the pharmacokinetic and pharmacodynamic profiles of these peptide agents [ Table 1 ], expanding their applications beyond T2DM and obesity to encompass cardiovascular disease event reduction [ Table 2 ]